Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Desamino Hydroxy Descyclopropyl Lenvatinib is a derivative compound of Lenvatinib (L329400), which functions as an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.
?您的位置：
